Skip to Content

Enzo Biochem Inc ENZ

Morningstar Rating
$1.09 −0.04 (3.54%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ENZ is trading at a 47% discount.
Price
$1.09
Fair Value
$1.24
Uncertainty
Extreme
1-Star Price
$4.54
5-Star Price
$9.69
Economic Moat
Jdhx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ENZ is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$1.13
Day Range
$1.071.12
52-Week Range
$1.072.74
Bid/Ask
$1.08 / $1.21
Market Cap
$55.84 Mil
Volume/Avg
258,158 / 116,728

Key Statistics

Price/Earnings (Normalized)
Price/Sales
1.74
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Value
Total Number of Employees
190

Comparables

Valuation

Metric
ENZ
TIHE
QSI
Price/Earnings (Normalized)
Price/Book Value
0.810.82
Price/Sales
1.74205.04
Price/Cash Flow
Price/Earnings
ENZ
TIHE
QSI

Financial Strength

Metric
ENZ
TIHE
QSI
Quick Ratio
2.5922.23
Current Ratio
3.2022.94
Interest Coverage
Quick Ratio
ENZ
TIHE
QSI

Profitability

Metric
ENZ
TIHE
QSI
Return on Assets (Normalized)
−1.96%−27.02%
Return on Equity (Normalized)
−3.38%−29.37%
Return on Invested Capital (Normalized)
−3.68%−30.81%
Return on Assets
ENZ
TIHE
QSI
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncChdwfsspRpj$206.7 Bil
DHR
Danaher CorpYlpmhxxyJpsmv$175.0 Bil
IQV
IQVIA Holdings IncMhqrfrhGcrkt$41.3 Bil
IDXX
IDEXX Laboratories IncSklpfzthvmCynwfp$39.6 Bil
A
Agilent Technologies IncCyvddpcxhMqtpq$38.8 Bil
MTD
Mettler-Toledo International IncDwbjpjmfyDtwgcyv$25.5 Bil
ICLR
Icon PLCVjghjlhpfWcbbvmh$23.8 Bil
ILMN
Illumina IncYnxdhmnxHxgjpzw$18.6 Bil
WAT
Waters CorpKjzxytjsTtrx$18.0 Bil
LH
Laboratory Corp of America HoldingsPcwpdgkjyNsymv$16.8 Bil

Sponsor Center